Concepedia

Jiancheng Lv

JL

13

Publications

350

Citations

11

H-Index

2006

Active since

Affiliations

Nanjing Medical University(Current)

Jiangsu Province Hospital

Jiancheng Lv is an author at Nanjing Medical University specializing in medicine, cell biology, and gene expression.

ORCID

Top concepts

Publications per year

2006–2024

13

Publications

13

HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway

Jiancheng Lv, Kai Li, Hao Yu et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 84 citations · Full text

The BCL2 major breakpoint region (mbr) regulates gene expression

Changyan Ma, J Zhang, L K Durrin et al. · Oncogene · 2006 · 35 citations

, , +6

CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway

Dexiang Feng, Jiancheng Lv, Kai Li et al. · Cell Biology and Toxicology · 2022 · 30 citations

, , +11

METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway

Hao Yu, Juntao Zhuang, Zijian Zhou et al. · International Journal of Biological Sciences · 2024 · 30 citations · Full text

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity

Xiao Yang, Jiancheng Lv, Zijian Zhou et al. · Frontiers in Oncology · 2022 · 29 citations · Full text

Rows per page

1–5 of 13